A detailed history of Capital World Investors transactions in Pfizer Inc stock. As of the latest transaction made, Capital World Investors holds 53,688,205 shares of PFE stock, worth $1.34 Billion. This represents 0.25% of its overall portfolio holdings.

Number of Shares
53,688,205
Previous 88,142,664 39.09%
Holding current value
$1.34 Billion
Previous $2.47 Billion 37.0%
% of portfolio
0.25%
Previous 0.41%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$27.7 - $31.39 $954 Million - $1.08 Billion
-34,454,459 Reduced 39.09%
53,688,205 $1.55 Billion
Q2 2024

Aug 13, 2024

SELL
$25.26 - $29.6 $619 Million - $726 Million
-24,518,817 Reduced 21.76%
88,142,664 $2.47 Billion
Q1 2024

May 14, 2024

SELL
$25.89 - $29.73 $1.57 Billion - $1.81 Billion
-60,732,791 Reduced 35.03%
112,661,481 $3.13 Billion
Q4 2023

Feb 13, 2024

SELL
$26.13 - $33.94 $230 Million - $299 Million
-8,798,010 Reduced 4.83%
173,394,272 $4.99 Billion
Q3 2023

Nov 13, 2023

SELL
$32.09 - $37.51 $540 Million - $631 Million
-16,820,524 Reduced 8.45%
182,192,282 $6.04 Billion
Q2 2023

Aug 11, 2023

SELL
$36.12 - $41.79 $1.17 Billion - $1.36 Billion
-32,499,562 Reduced 14.04%
199,012,806 $7.3 Billion
Q1 2023

May 15, 2023

SELL
$39.39 - $51.28 $968 Million - $1.26 Billion
-24,584,436 Reduced 9.6%
231,512,368 $9.45 Billion
Q4 2022

Feb 14, 2023

BUY
$41.75 - $54.5 $303 Million - $395 Million
7,246,275 Added 2.91%
256,096,804 $13.1 Billion
Q3 2022

Nov 14, 2022

SELL
$43.76 - $53.42 $55.8 Million - $68.2 Million
-1,276,218 Reduced 0.51%
248,850,529 $10.9 Billion
Q2 2022

Aug 15, 2022

BUY
$46.53 - $55.17 $1.41 Billion - $1.67 Billion
30,250,912 Added 13.76%
250,126,747 $13.1 Billion
Q1 2022

May 16, 2022

SELL
$45.75 - $56.69 $777 Million - $963 Million
-16,982,581 Reduced 7.17%
219,875,835 $11.4 Billion
Q4 2021

Feb 14, 2022

SELL
$41.32 - $61.25 $186 Million - $276 Million
-4,502,442 Reduced 1.87%
236,858,416 $14 Billion
Q3 2021

Nov 15, 2021

BUY
$39.25 - $50.42 $46 Million - $59.1 Million
1,171,443 Added 0.49%
241,360,858 $10.4 Billion
Q2 2021

Aug 16, 2021

BUY
$35.91 - $40.68 $363 Million - $411 Million
10,103,021 Added 4.39%
240,189,415 $9.41 Billion
Q1 2021

May 14, 2021

SELL
$33.49 - $37.77 $1.22 Billion - $1.38 Billion
-36,561,224 Reduced 13.71%
230,086,394 $8.34 Billion
Q4 2020

Feb 12, 2021

BUY
$33.47 - $42.56 $250 Million - $318 Million
7,461,321 Added 2.88%
266,647,618 $9.82 Billion
Q3 2020

Nov 13, 2020

BUY
$31.75 - $37.25 $468 Million - $549 Million
14,747,788 Added 6.03%
259,186,297 $9.51 Billion
Q2 2020

Aug 14, 2020

BUY
$30.12 - $36.54 $591 Million - $717 Million
19,630,396 Added 8.73%
244,438,509 $7.99 Billion
Q1 2020

May 15, 2020

BUY
$27.03 - $38.62 $976 Million - $1.39 Billion
36,092,723 Added 19.13%
224,808,113 $7.34 Billion
Q4 2019

Feb 18, 2020

BUY
$32.92 - $37.36 $732 Million - $831 Million
22,232,056 Added 13.35%
188,715,390 $7.39 Billion
Q3 2019

Nov 14, 2019

BUY
$32.49 - $42.13 $146 Million - $189 Million
4,492,241 Added 2.77%
166,483,334 $5.98 Billion
Q2 2019

Aug 14, 2019

BUY
$36.98 - $41.52 $505 Million - $567 Million
13,656,468 Added 9.21%
161,991,093 $7.02 Billion
Q1 2019

May 15, 2019

BUY
$37.5 - $41.2 $859 Million - $944 Million
22,911,985 Added 18.27%
148,334,625 $6.3 Billion
Q4 2018

Feb 14, 2019

BUY
$38.47 - $43.86 $1.55 Billion - $1.77 Billion
40,389,680 Added 47.5%
125,422,640 $5.47 Billion
Q3 2018

Nov 14, 2018

BUY
$34.47 - $41.81 $1.63 Billion - $1.97 Billion
47,202,436 Added 124.77%
85,032,960 $3.75 Billion
Q2 2018

Aug 14, 2018

BUY
$32.98 - $35.16 $689 Million - $735 Million
20,895,524 Added 123.39%
37,830,524 $1.37 Billion
Q3 2017

Nov 14, 2017

BUY
$31.0 - $34.15 $525 Million - $578 Million
16,935,000
16,935,000 $605 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $140B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Capital World Investors Portfolio

Follow Capital World Investors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital World Investors, based on Form 13F filings with the SEC.

News

Stay updated on Capital World Investors with notifications on news.